Safety and Tolerability Study of Inhaled Carbon Monoxide in Kidney Transplant Patients

NCT00531856 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Clinical Hold pending additional data review and protocol amendment

Conditions

Kidney Transplantation

Interventions

DRUG: Inhaled carbon monoxide
DRUG: Inhaled carbon monoxide
DRUG: Inhaled carbon monoxide
DRUG: Inhaled Carbon Monoxide
DRUG: Inhaled Carbon Monoxide

Sponsor

Mallinckrodt